2016年《EULAR对系统性硬化症治疗推荐的更新》评析(3)
[6] Schiopu E， Hsu VM， Impens AJ， et al. Randomized placebo-controlled crossover trial of tadalafil in Raynaud’s phenomenon secondary to systemic sclerosis [J]. J Rheumatol， 2009， 36(10)： 2264-2268.
[7] Shenoy PD， Kumar S， Jha LK， et al. Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy： a double-blind randomized cross-over trial [J]. Rheumatology (Oxford) ......
您现在查看是摘要页，全文长 2841 字符。
[7] Shenoy PD， Kumar S， Jha LK， et al. Efficacy of tadalafil in secondary Raynaud’s phenomenon resistant to vasodilator therapy： a double-blind randomized cross-over trial [J]. Rheumatology (Oxford) ......
您现在查看是摘要页，全文长 2841 字符。